Integration of PT in an existing radiation oncology center

Size: px
Start display at page:

Download "Integration of PT in an existing radiation oncology center"

Transcription

1 Integration of PT in an existing radiation oncology center Tom Depuydt, PhD Head of medical Physics, Radiation Oncology UZ Leuven-KU Leuven and ParTICLe proton therapy project 1

2 Milestones in the history of Proton Therapy (PT) Custom built installations First patients treated with PT at Harvard Cyclotron Lab. and Massachusetts General Hospital First patients treated with Pencil Beam Scanning Founding father of PT *PBS = Pencil Beam Scanning

3 History of Proton Therapy (PT) facilities PT facilities evolves from being A by-product NUCLEAR PHYSICS RESEARCH FACILITY PT

4 PT as add-on to large nuclear research infrastructure Large nuclear research facility (Paul Scherrer Institute) Clinical proton therapy facility

5 PT as add-on to large nuclear research infrastructure One clinical beamline connected to large research accelerator facility (shared) Non-commercial custom built systems by facilities own physics/engineering team Often access to other particles beside protons such as carbon ions Low patient through-put Not in close proximity of a hospital Available a few months per year due to maintenance Limited support, remote involvement of a conventional radiotherapy clinical Staff are mainly scientist from research facility High number of people required to run the facility Experimental stage and not cost effective PRICE:??? (cannot be seen separate from research facility) Research facility layout

6 Milestones in the history of Proton Therapy (PT) Custom built installations Commercial installations First patients treated with PT at Harvard Cyclotron Lab. and Massachusetts General Hospital Founding father of PT First patients treated with Pencil Beam Scanning 2010 PBS in other facilities (MGH, MDA, ) 2013 *PBS = Pencil Beam Scanning

7 History of Proton Therapy (PT) facilities PT facilities evolves from being A by-product NUCLEAR PHYSICS RESEARCH FACILITY PT Dedicated stand-alone facility PT

8 PT as a large dedicated stand alone facility APSS Trento, Italy Holland PTC, Delft, The Netherlands Scripps, San Diego, USA

9 PT as a large dedicated stand alone facility Large facility built for the purpose of proton therapy Mostly commercial systems Dedicated accelerator serving typically 2 to 5 treatment rooms including fixed beam and gantry rooms Mostly only proton beam Not directly connected or in close proximity of hospital Potentially high throughput Different PT techniques available in one facility (PS, PBS, eye-beam-line) Stand-alone facility not sharing equipment or work-flow with existing radiation oncology department Usually its own treatment preparation imaging (CT, PET, MRI, ) Clinically oriented staff, but usually proton therapy only specialized experts, and large technical staff to run the system Sometimes one room available for research PRICE: projects of 100M Euro

10 Milestones in the history of Proton Therapy (PT) Custom built installations Commercial installations First patients treated with PT at Harvard Cyclotron Lab. and Massachusetts General Hospital Founding father of PT First patients treated with Pencil Beam Scanning 2010 PBS in other facilities (MGH, MDA, ) 2013 *PBS = Pencil Beam Scanning

11 Gartner Hype Cycle for Proton Therapy -Too expensive anyway -Too experimental -Not cure more patients -No level 1 evidence -Moving tumors impossible - Climbing the slope of enlightenment

12 Milestones in the history of Proton Therapy (PT) Custom built installations Commercial installations Compact commercial installations First patients treated with PT at Harvard Cyclotron Lab. and Massachusetts General Hospital Founding father of PT First patients treated with Pencil Beam Scanning 2010 PBS in other facilities (MGH, MDA, ) 2013 First compact system clinically used *PBS = Pencil Beam Scanning

13 PT embedded in existing radiation oncology clinic The metaphors in PT Size measure of PT centers Range uncertainty 60x100 meter

14 PT embedded in existing radiation oncology clinic Compact systems as enabling technology for embedding PT? 11x24 meter 15x28 meter

15 History of Proton Therapy (PT) facilities PT facilities evolves from being A by-product NUCLEAR PHYSICS RESEARCH FACILITY PT Dedicated stand-alone facility PT Embedded Facility HOSPITAL PT

16 PT embedded in existing radiation oncology clinic dose Photons, electrons dose Charged particles (e -,p +, ) depth PT seen as an additional modality, rather than an separate facility depth

17 PT embedded in existing radiation oncology clinic

18 PT embedded in existing radiation oncology clinic Proton therapy Conventional RT

19 PT embedded in existing radiation oncology clinic Existing cancer care Proton therapy Proton therapy

20 PT embedded in existing radiation oncology clinic UZ Leuven campus Gasthuisberg Impression of finished facility

21 ParTICLe Proton Therapy Project in Leuven Clinical Treatment room 1 Research room (future clinical 2) 23m A B 60m Existing+Future(2020) Radiation Oncology dept., UZ Leuven C Lab Access MRI s MRI s PET-MRI D

22 ParTICLe Proton Therapy Project in Leuven PT Treatment MRI FUP scans Reception Intake/Status PT rooms Induction/ recovery Diagnostic MRI facility Waiting room Radiation Oncology dept. Backup XT treatment FUP CT scan Truebeam STX Halcyon Halcyon Truebeam Treatment planning Truebeam PT fully embedded in existing RT/hospital facility

23 PT embedded in existing radiation oncology clinic Smaller facility truly integrated in existing radiation oncology and hospital environment Commercial compact systems with one or 2 treatment rooms Proton beam only Pencil beam scanning (PBS) only (mostly) Sharing treatment preparation imaging equipment and clinical workflow with conventional radiation oncology and hospital Clinically oriented staff, shared but PT trained staff from XT clinic, with limited technical staff to run the facility Only clinical treatment room, no research beam-line PRICE: projects of 50 M EURO

24 Integrated compact proton therapy facilities Users Region Treating Integration P1 with adjacent RT unit or full oncology Proton Partners International Ltd 8 Europe No Yes but RT/full oncology unit in construction Proton Partners International Ltd 7 Europe No Yes but RT/full oncology unit in construction Proton Partners International Ltd 6 Europe No Yes but RT/full oncology unit in construction Children's Cancer Hospital Egypt (Hospital MENA No Yes but RT/full oncology unit in construction 57357) QuironSalud Madrid Europe No Yes but no onsite integration Proton Partners International Ltd 5 North America No Yes but RT/full oncology unit in construction Proton Partners International Ltd 4 Europe No Yes but RT/full oncology unit in construction Florida Proton Therapy Institute North America No No, addition to currently multi-room PT system Gulf International Cancer Center MENA No Yes but RT/full oncology unit in construction ParTICLe UZ Leuven Europe No Yes Proton Partners International Ltd 3 Europe No Yes but RT/full oncology unit in construction Proton Partners International Ltd 2 Europe No Yes but RT/full oncology unit in construction Proton Partners International Ltd 1 Europe No Yes but RT/full oncology unit in construction CYCLHAD Caen Europe No Yes but no onsite integration William Beaumont Hospital North America Yes Yes Toyohashi University of Technology Asia No Yes Hokkaido University Hospital Asia No Yes Chiu Ho Medical Systems Co., Ltd. Asia No Yes Changhua Christian Hospital Asia No Yes Centre Antoine Lacassagne (CAL) Europe Yes Few miles away from RT unit but integrated with Cyberknife Willis-Knighton Medical Center North America Yes Yes

25 History of Proton Therapy (PT) facilities PT facilities evolves from being A by-product NUCLEAR PHYSICS RESEARCH FACILITY PT Dedicated stand-alone facility PT Embedded Facility HOSPITAL PT

26 Large Multi-room vs. Compact unit Location of radiation sources Cyclotron Energy Selection System Nozzle Patient Degrader Collimator Divergence slits Momentum slits 32m 60m 27m 11m

27 Large Multi-room vs. Compact unit Concrete activation/dismantling nuclear waste: The walls in vaults for compact systems can be closer to the cyclotron, resulting in higher intensity of neutron fluence on the wall. The specific activity after 20 years due to long-lived isotopes ( 152 Eu, 60 Co) will be larger Using a decommissioning layer of low activation concrete, Norwegian Marble aggregates with low Eu levels <0.1ppm

28 Public Exposure limits of Embedded facilities Clinical Treatment room 1 Research room (future clinical 2) Existing Offices/Public spaces Public Exposure limits (FANC): <300 μsv/year, <20 μsv/week, <10 μsv/h ParTICLe (Particle Therapy Interuniversitary Center Leuven)

29 Training people for PT in embedded facility XT +PT Physicians expertise Physics expertise Technologist expertise XT experience, PT-specific experience Train existing XT team rather then attract PT expertise externally? How much training? Send people abroad to other PT centers for a longer time or not? Dedicated PT team or a more integrated approach with XT? Internal organization of RT to include the PT modality?

30 Training people for PT in embedded facility Passive scattering (PS) Pencil beam scanning (PBS) PS Proven technology with which most PT patients are treated today, but labor intensive and not PBS Flexible technology with great potential, but... Vendors have made this choice for us in compact PT systems

31 Training people for PT in embedded facility Technical knowledge PT and related equipment Software environment (TPS+OIS) Most commercial TPS have PT planning Specific issues with PBS planning Introduction of robust planning

32 Technological cross-talk between XT and PT 1999: David Jaffray and first CBCT integrated in linac 2016: First CBCT-guided PT And the rest is history

33 Technological cross-talk between XT and PT XT Volumetric image guidance IMRT PT (CBCT only recently introduced in PT) (IMPT find its way to mainstream PT) Adaptive Radiotherapy (revival in XT?) RT of moving tumors Will finds its way to XT (Probably more needed in PT) (Issues to solve in PBS, triggers development of motion management strategies in PBS-only environments) PTV-less robust planning strategies Classic margin recipes invalid?! Cross-talk between XT and PT could be intensified by embedded facilities

34 Training people for PT in embedded facility (RTT) Treatment delivery and IGRT interfaces become similar in XT and PT PT system user interface XT system user interface

35 Aspects of setting up a mixed XT/PT environment System for optimal patient-specific selection between XT and PT modalities Adaptive Workflow protocols XT PT XT Less bias in choice between XT and PT in a true mixed/integrated environment? PT Courtesy M. Engelsman (TU Delft) Approaches supported by TPS+OIS environment. Interaction between TPS and OIS?

36 International guidelines for PT/PBS? The current activity of different guideline working groups shows that PBS is getting to maturity, but it is not there yet. It also shows that existing guidelines do not meet the current needs. (C. Goma, PhD, UZ Leuven) Publishes guidelines AAPM Report 16 (1986), Protocol for heavy charged-particle therapy beam dosimetry, no PBS ICRU Report 59 (1998), Clinical Proton dosimetry, no PBS IAEA TRS-398 (2000), The current Code of Practice for proton dosimetry no PBS ICRU Report 78 (2007), coverage PBS limited Guidelines in preparation IAEA: Update of TRS-398 (<2020?) AAPM TG-185: Commissioning of Proton Therapy Systems AAPM TG-224: Proton Machine QA NCS subcommittee on proton dosimetry EPTN ("ESTRO initiative") IPEM

37 Particle Therapy Interuniversitary Center Leuven 2014 Timelapse Sept Today

38 Particle Therapy Interuniversitary Center Leuven Last week Next 4 weeks In < 1 year 1x 2x In-room CT on-rails

39 Particle Therapy Interuniversitary Center Leuven Overview Contract signature Today 1 st Patient Construction Power supply & cooling Installation proton equipment & ATP Commissioning First patient

40 Concluding remarks Embedded Facility HOSPITAL PT Compact PT systems will facilitate embedding of PT facilities in an existing hospital campus Embedded facilities have an impact on the organization of PT: Located in close proximity/adjacent to existing general hospital/existing RT service Allow better integration in existing RT organization, in all aspects Potentially will amplify the interaction/crosstalk between PT and conventional RT/XT This integration can play a role in coming to optimal choice of treatment modality, PT vs XT

Jefferies Healthcare Conference

Jefferies Healthcare Conference Jefferies Healthcare Conference Jean-Marc BOTHY - CSO June 8, 2017 2017 IBA SA Disclaimer This presentation may contain forward-looking statements concerning industry outlook, including growth drivers;

More information

Proton Beam Therapy at Mayo Clinic

Proton Beam Therapy at Mayo Clinic Proton Beam Therapy at Mayo Clinic Jon J. Kruse, Ph.D. Mayo Clinic Dept. of Radiation Oncology Rochester, MN History of Proton Therapy at Mayo 2002: Decided to consider particle therapy analysis and education

More information

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan

Learning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan Overview of Quality Assurance in Proton Therapy Omar Zeidan AAPM 2012 Charlotte, NC July 30 st, 2012 Learning Objectives Understand proton beam dosimetry characteristics and compare them to photon beams

More information

Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment

Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment Barry W. Wessels, Ph.D. Director of Medical Physics and Dosimetry Case Western Reserve

More information

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.

More information

Image Guided Proton Therapy and Treatment Adaptation

Image Guided Proton Therapy and Treatment Adaptation Image Guided Proton Therapy and Treatment Adaptation www.hollandptc.nl d.r.schaart@tudelft.nl Cancer in The Netherlands About 1 in 3 people get cancer in some stage of their life 86.800 new cancer patients

More information

Radiation treatment planning in lung cancer

Radiation treatment planning in lung cancer Radiation treatment planning in lung cancer Georg Dietmar 1,2 1 Div. Medical Rad. Phys., Dept. of Radiation Oncology / Medical Univ. Vienna & AKH Wien 2 Christian Doppler Laboratory for Medical Radiation

More information

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy Departments of Oncology and Medical Biophysics Accuracy Requirements and Uncertainty Considerations in Radiation Therapy Introduction and Overview 6 August 2013 Jacob (Jake) Van Dyk Conformality 18 16

More information

SUMITOMO Particle Therapy Technologies

SUMITOMO Particle Therapy Technologies 55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future

More information

New Radiation Health Technologies Challenges, Opportunities, Limitations

New Radiation Health Technologies Challenges, Opportunities, Limitations New Radiation Health Technologies Challenges, Opportunities, Limitations IRPA-13 Glasgow Fridtjof Nuesslin Klinik für Strahlentherapie und Radiologische Onkologie 2012-IIRPA13 Radiation Health Technologies

More information

Radiation protection in proton therapy

Radiation protection in proton therapy Radiation protection in proton therapy Pieternel van der Tol Medical Physicist - HollandPTC pvandertol@hollandptc.nl Marjan Dwarswaard René Bolt Marc-Jan van Goethem Lars Murrer Outline Introduction Interactions

More information

Plans for the Precision Cancer Medicine Institute University of Oxford

Plans for the Precision Cancer Medicine Institute University of Oxford Plans for the Precision Cancer Medicine Institute University of Oxford STFC & Particle Accelerators and Beams group workshop on particle accelerators for medicine 17 th February 2015 Claire Timlin The

More information

IBA Dosimetry Company Presentation. Patient Safety & Quality Control

IBA Dosimetry Company Presentation. Patient Safety & Quality Control IBA Dosimetry Company Presentation Patient Safety & Quality Control IBA Mission Protect, enhance and save lives Protect, Enhance, and Save Lives - 2 - The History of IBA Dosimetry A story of innovation

More information

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen : Medical Operation of the 2 nd Machine, Production and Commissioning Status of Machines No. 3 to 7 H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen VARIAN Medical Systems Particle

More information

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017 FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips

More information

Treatment Efficiency and Optimization of Patient Care with IBA ProteusOne

Treatment Efficiency and Optimization of Patient Care with IBA ProteusOne Treatment Efficiency and Optimization of Patient Care with IBA ProteusOne Terry Wu, Ph.D. Chief Physicist, Radiation Oncology Department Willis-Knighton Cancer Center/Proton Therapy Center Shreveport,

More information

SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES

SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES SHIELDING TECHNIQUES FOR CURRENT RADIATION THERAPY MODALITIES MELISSA C. MARTIN, M.S., FACR, FAAPM PRESIDENT AAPM - 2017 PRESIDENT - THERAPY PHYSICS INC., GARDENA, CA MELISSA@THERAPYPHYSICS.COM AAPM Spring

More information

6/29/2012 WHAT IS IN THIS PRESENTATION? MANAGEMENT OF PRIMARY DEVICES INVESTIGATED MAJOR ISSUES WITH CARDIAC DEVICES AND FROM MED PHYS LISTSERVS

6/29/2012 WHAT IS IN THIS PRESENTATION? MANAGEMENT OF PRIMARY DEVICES INVESTIGATED MAJOR ISSUES WITH CARDIAC DEVICES AND FROM MED PHYS LISTSERVS 6/29/2012 MANAGEMENT OF RADIOTHERAPY PATIENTS WITH IMPLANTED CARDIAC DEVICES Dimitris Mihailidis, PhD., Charleston Radiation Therapy Consultants Charleston, WV 25304 WHAT IS IN THIS PRESENTATION? Types

More information

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009

The Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 The Heidelberg Ion Therapy Center Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 Goal The key element to improve the clinical outcome is local l control! entrance channel:

More information

United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 United States Proton Therapy Market (Actual & Potential), Patients Treated,

More information

Are Transmission Detectors a Necessary Tool for a Safe Patient Radiation Therapy Program?

Are Transmission Detectors a Necessary Tool for a Safe Patient Radiation Therapy Program? Are Transmission Detectors a Necessary Tool for a Safe Patient Radiation Therapy Program? Can you currently use direct documentation and measurement of delivered dose to ensure you did not underdose or

More information

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) Course Description: This course is an introduction to physics in medicine and is intended to introduce

More information

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca

More information

1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán

1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán Risk in Dosimetry. Industry Stand point 1ª Jornada de Análisis de Riesgos en RT. 10 de Dic 2014 José Luis Roldán Agenda IBA. IBA Dosimetry Risks in Dosimetry Product development Product manufacturing Product

More information

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center

Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center The Heidelberg Ion Beam Therapy Center A Hospital-based Facility Dedicated to Precision and Flexibility Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center Carbon Ion Therapy

More information

Elekta Synergy Digital accelerator for advanced IGRT

Elekta Synergy Digital accelerator for advanced IGRT Elekta Synergy Digital accelerator for advanced IGRT Setting the standard for confident care The Field of Radiation Therapy is Constantly Changing Being able to take full advantage of the latest clinical

More information

Press release Regulated information

Press release Regulated information IBA TRADING UPDATE - THIRD QUARTER 2013 Pick up in revenues over H1 2013 due to good order book conversion Company on track to be selected for eight new proton therapy (PT) rooms in 2013 REBIT margin for

More information

PROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION

PROTON THERAPY. Proton Therapy Edition 2016 WORLD MARKET REPORT & DIRECTORY EDITION Proton Therapy Edition 2016 PROTON THERAPY WORLD MARKET REPORT & DIRECTORY EDITION 2016 A report written by Paul-Emmanuel Goethals & Richard Zimmermann Page 1/7 www.medraysintell.com Proton Therapy Edition

More information

Efficient Dosimetry for Proton Therapy

Efficient Dosimetry for Proton Therapy Efficient Dosimetry for Proton Therapy Why IBA Dosimetry? IBA Dosimetry offers the full product range tailored to fit any Proton Therapy QA needs. PT treatment safety, as well as most efficient dosimetry

More information

Applications of Particle Accelerators

Applications of Particle Accelerators Applications of Particle Accelerators Prof. Rob Edgecock STFC Rutherford Appleton Laboratory EMMA Accelerator at Daresbury Laboratory Applications >30000 accelerators in use world-wide: 44% for radiotherapy

More information

iba-dosimetry.com INTEGRATED QUALITY ASSURANCE Solution Overview

iba-dosimetry.com INTEGRATED QUALITY ASSURANCE Solution Overview iba-dosimetry.com Solution Overview 2 3 IBA DOSIMETRY WHY? Protect, Enhance and Save Lives At IBA we share ideas and know-how with our customers and partners to provide innovative solutions for the diagnosis

More information

PROGRESS IN HADRONTHERAPY

PROGRESS IN HADRONTHERAPY PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy

More information

State-of-the-art proton therapy: The physicist s perspective

State-of-the-art proton therapy: The physicist s perspective State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New

More information

Specifics of treatment planning for active scanning and IMPT

Specifics of treatment planning for active scanning and IMPT Specifics of treatment planning for active scanning and IMPT SFUD IMPT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Treatment planning for scanning 1. Single Field,

More information

IMAGE-GUIDED RADIATION THERAPY

IMAGE-GUIDED RADIATION THERAPY IMAGE-GUIDED RADIATION THERAPY Your Single Source Oncology Solutions Provider Plan. Target. Treat. At Best NOMOS, we design products and solutions that help medical professionals treat a variety of cancers.

More information

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May IONTRIS Synchrotron based PT Solutions from Siemens AG Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May 1 2009 Matthias Herforth VP Business Development and Communications Siemens AG

More information

Advances in external beam radiotherapy

Advances in external beam radiotherapy International Conference on Modern Radiotherapy: Advances and Challenges in Radiation Protection of Patients Advances in external beam radiotherapy New techniques, new benefits and new risks Michael Brada

More information

Future upcoming technologies and what audit needs to address

Future upcoming technologies and what audit needs to address Future upcoming technologies and what audit needs to address Dr R.I MacKay History of audit Absolute dose - Simple phantom standard dose measurement Point doses in beams - Phantoms of relatively simple

More information

Proton Therapy Market Outlook - Global Analysis

Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen

More information

Clinical Quality Assurance for Particle Therapy Plus ça même Plus

Clinical Quality Assurance for Particle Therapy Plus ça même Plus Clinical Quality Assurance for Particle Therapy Plus ça même Plus Thomas F. DeLaney, MD Medical Director Francis H. Burr Proton Center Massachusetts General Hospital Boston MA Quality Assurance Designed

More information

Amendment No. 2. Item No. 2 (Rfx/ Event number )

Amendment No. 2. Item No. 2 (Rfx/ Event number ) Amendment 2 Sub: Amendment to the Document 06.12.2018 Ref.: Notice Inviting Bid ref. HITES/PCD/NCI-AIIMS/36/18-19 dated 26.09.2018 read with its Amendment no. 1 dated 19.11.18 The following changes have

More information

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center

The Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center The Heidelberg Ion Therapy Center and PARTNER Thomas Haberer Heidelberg Ion Therapy Center Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low

More information

Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton

More information

Ion Beam Therapy should we prioritise research on helium beams?

Ion Beam Therapy should we prioritise research on helium beams? Ion Beam Therapy should we prioritise research on helium beams? Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION Beam Therapy: Clinical, Scientific

More information

SRS Uncertainty: Linac and CyberKnife Uncertainties

SRS Uncertainty: Linac and CyberKnife Uncertainties SRS Uncertainty: Linac and CyberKnife Uncertainties Sonja Dieterich, PhD Linac/CyberKnife Technological Uncertainties 1 Linac Mechanical/Radiation Isocenters Depuydt, Tom, et al. "Computer aided analysis

More information

Proton and heavy ion radiotherapy: Effect of LET

Proton and heavy ion radiotherapy: Effect of LET Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer

More information

HEAVY PARTICLE THERAPY

HEAVY PARTICLE THERAPY HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER

More information

Innovations in Radiation Therapy, including SBRT, IMRT, and Proton Beam Therapy. Sue S. Yom, M.D., Ph.D.

Innovations in Radiation Therapy, including SBRT, IMRT, and Proton Beam Therapy. Sue S. Yom, M.D., Ph.D. Innovations in Radiation Therapy, including SBRT, IMRT, and Proton Beam Therapy Sue S. Yom, M.D., Ph.D. Disclosures Genentech: advisory, research support ImClone: research support Plexxikon: research support

More information

CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT

CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT Purpose The purpose of this curriculum outline is to provide a framework for multidisciplinary training for radiation oncologists, medical

More information

Albert Lisbona Medical Physics Department CLCC Nantes Atlantique a

Albert Lisbona Medical Physics Department CLCC Nantes Atlantique a The Equipment : safety, commissioning, re commissioning calibration : Equipements : sûreté, recette, modification calibration A medical physicist point of view. Albert Lisbona Medical Physics Department

More information

Data Collected During Audits for Clinical Trials. July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff

Data Collected During Audits for Clinical Trials. July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff Data Collected During Audits for Clinical Trials July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff RPC Programs Assure... Constancy of basic machine calibration (TLD/OSLD Audits) Validity of treatment

More information

The TomoTherapy System as a Tool of Differentiation in Quality and Marketability

The TomoTherapy System as a Tool of Differentiation in Quality and Marketability The TomoTherapy System as a Tool of Differentiation in Quality and Marketability John J. Kresl, MD, PhD, FACRO, FACR Medical Director Phoenix CyberKnife & Radiation Oncology Center Managing Partner Phoenix,

More information

I. Equipments for external beam radiotherapy

I. Equipments for external beam radiotherapy I. Equipments for external beam radiotherapy 5 linear accelerators (LINACs): Varian TrueBeam 6, 10 & 18 MV photons, 6-18 MeV electrons, image-guided (IGRT) and intensity modulated radiotherapy (IMRT),

More information

New Treatment Research Facility Project at HIMAC

New Treatment Research Facility Project at HIMAC New Treatment Research Facility Project at Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences IPAC10, Kyoto, JAPAN, 25th May, 2010 Contents 1. Introduction

More information

Range Uncertainties in Proton Therapy

Range Uncertainties in Proton Therapy Range Uncertainties in Proton Therapy Harald Paganetti PhD Professor of Radiation Oncology, Harvard Medical School Director of Physics Research, Massachusetts General Hospital, Department of Radiation

More information

Catharine Clark NPL, Royal Surrey County Hospital and RTTQA

Catharine Clark NPL, Royal Surrey County Hospital and RTTQA Catharine Clark NPL, Royal Surrey County Hospital and RTTQA Background Historically UK has been relatively independent of the rest of the world in audit NPL PSDL International intercomparison for reference

More information

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center

The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center Thomas Haberer, Scientific Technical Director, Heidelberg Ion Therapy Center Situation / Indications 2/3 patients suffer

More information

Quality Assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iplan RT Dose

Quality Assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iplan RT Dose Petrovic B Comparison of dose calculation algorithms for stereotaxy Quality Assurance of TPS: comparison of dose calculation for stereotactic patients in and RT Dose Borislava Petrovic 1, Aleksandra Grządziel

More information

Elekta Infinity. Digital accelerator for advanced treatments. Redefining treatment precision, speed and control

Elekta Infinity. Digital accelerator for advanced treatments. Redefining treatment precision, speed and control Elekta Infinity Digital accelerator for advanced treatments Redefining treatment precision, speed and control Do you have the confidence to increase conformance and speed without compromising target coverage?

More information

Guideline & Reports 医学物理学会教育委員会資料

Guideline & Reports 医学物理学会教育委員会資料 Guideline & Reports 医学物理学会教育委員会資料 2017/11 更新 report title year keyword 1 keyword 2 AAPM TG211 Classification and evaluation strategies of auto-segmentation approaches for PET 2017 PET autosegmentation

More information

Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR

Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR Linac or Non-Linac Demystifying And Decoding The Physics Of SBRT/SABR PhD, FAAPM, FACR, FASTRO Department of Radiation Oncology Indiana University School of Medicine Indianapolis, IN, USA Indra J. Das,

More information

JP MORGAN HEALTHCARE CONFERENCE DOW R. WILSON President and Chief Executive Officer 1 FOR INVESTOR USE ONLY

JP MORGAN HEALTHCARE CONFERENCE DOW R. WILSON President and Chief Executive Officer 1 FOR INVESTOR USE ONLY JP MORGAN HEALTHCARE CONFERENCE - 2017 DOW R. WILSON President and Chief Executive Officer 1 FOR INVESTOR USE ONLY THIS PRESENTATION IS INTENDED EXCLUSIVELY FOR INVESTORS. IT IS NOT INTENDED FOR USE IN

More information

The Best in Proton Therapy + Today and Tomorrow + IBA. Corporate Presentation. February 2017

The Best in Proton Therapy + Today and Tomorrow + IBA. Corporate Presentation. February 2017 The Best in Proton Therapy + Today and Tomorrow + IBA Corporate Presentation February 2017 Disclaimer This presentation may contain forward-looking statements concerning industry outlook, including growth

More information

Precisely Maximize Dose, side effects, Patient

Precisely Maximize Dose, side effects, Patient Precisely Maximize Dose, Minimize side effects, Maximize Patient Comfort Key Differentiators: The CyberKnife M6 Series Industry-leading precision and patient comfort Enables full-body robotic radiosurgery,

More information

Your Global Quality Assurance Platform All-in-One. All Connected. All Secure.

Your Global Quality Assurance Platform All-in-One. All Connected. All Secure. Your Global Quality Assurance Platform All-in-One. All Connected. All Secure. www.iba-dosimetry.com Dealing with complexity in your QA? All-in-One. Linacs OK Patients OK Reports APPROVED Satellite Center

More information

Current NCS Subcommittees

Current NCS Subcommittees Nederlandse Commissie voor Stralingsdosimetrie Netherlands Commission on Radiation Dosimetry Current NCS Subcommittees And other activities Two main Activities Platform More government oriented activities

More information

8/2/2018. Disclosures. In ICRU91: SRT = {SBRT/SABR, SRS}

8/2/2018. Disclosures. In ICRU91: SRT = {SBRT/SABR, SRS} High Dose, Small Field Radiation Therapy: Lessons from the HyTEC Project and the ICRU 91 Report Part 1: Small Field Dosimetry Jan Seuntjens, Ph.D, FCCPM, FAAPM, FCOMP Director and Professor, Medical Physics

More information

The Current & Future State of Particle Therapy

The Current & Future State of Particle Therapy The Current & Future State of Particle Therapy The MD Anderson Proton Therapy Center- Houston Matthew Palmer, MBA, CMD Chief Operating Officer mpalmer@mdanderson.org The Challenge PlanIQ TM, Courtesy of

More information

Session 17 Practical Implementation of New Technologies in Low-to-Middle Income Countries

Session 17 Practical Implementation of New Technologies in Low-to-Middle Income Countries 17 Practical Implementation of New Technologies in LMICs Session 17 Practical Implementation of New Technologies in Low-to-Middle Income Countries Introduction Jacob (Jake) VanDyk Western University London,

More information

THE BEST IN PROTON THERAPY TODAY AND TOMORROW

THE BEST IN PROTON THERAPY TODAY AND TOMORROW THE BEST IN PROTON THERAPY TODAY AND TOMORROW The figures speak for themselves As the leading provider of Proton Therapy, IBA is committed to making this advanced treatment available to cancer patients

More information

Nano-X A Smarter and Smaller Cancer Radiotherapy System

Nano-X A Smarter and Smaller Cancer Radiotherapy System Nano-X A Smarter and Smaller Cancer Radiotherapy System Paul Keall, Ilana Feain, Chun-Chien Shieh, Brendan Whelan, Peter Bennett, Paul Liu, Jeff Barber, Michael Barton, Simon Downes, Michael Jackson, +++

More information

Proton therapy From the Need to the Solution

Proton therapy From the Need to the Solution BELGISCHE VERENIGING VOOR STRALINGSBESCHERMING Sociale hoofdzetel c/o SCK-CEN Herrmann Debrouxlaan 40, B-1160 Brussel Secretariaat:Véronique Mertens c/o FANC/AFCN Ravensteinstraat 36, 1000 Brussel 02 289

More information

Changing Paradigms in Radiotherapy

Changing Paradigms in Radiotherapy Changing Paradigms in Radiotherapy Marco van Vulpen, MD, PhD Mouldroomdag-2015 Towards the elimination of invasion 1 NIH opinion on the future of oncology Twenty-five years from now,i hope that we won

More information

HALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy

HALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy The Physical and Biological Basis of By 1899 X rays were being used for cancer therapy David J. Brenner, PhD, DSc Center for Radiological Research Department of Radiation Oncology Columbia University Medical

More information

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante

HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS Prof. Marco Durante Risk from neutrons Risk from exposure to fission spectrum neutrons has been extensively studied in the 60 s at nuclear reactors using animal

More information

Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR.

Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact. Stephen F. Kry, Ph.D., D.ABR. Non-target dose from radiotherapy: Magnitude, Evaluation, and Impact Stephen F. Kry, Ph.D., D.ABR. Goals Compare out-of-field doses from various techniques Methods to reduce out-of-field doses Impact of

More information

S. Derreumaux (IRSN) Accidents in radiation therapy in France: causes, consequences and lessons learned

S. Derreumaux (IRSN) Accidents in radiation therapy in France: causes, consequences and lessons learned S. Derreumaux (IRSN) Accidents in radiation therapy in France: causes, consequences and lessons learned MEDICAL LINEAR ACCELERATORS Electron beam (MeV) Photon beam (MV) PRECISION REQUIRED IN RADIOTHERAPY

More information

Sarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington

Sarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Sarcoma and Radiation Therapy Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Objective: Helping you make informed decisions Introduction Process Radiation

More information

Clinical Education A comprehensive and specific training program. carry out effective treatments from day one

Clinical Education A comprehensive and specific training program. carry out effective treatments from day one Proton Therapy Clinical Education A comprehensive and specific training program carry out effective treatments from day one Forewarned is forearmed Although over 100,000 patients have been treated in proton

More information

QA for Clinical Dosimetry with Emphasis on Clinical Trials

QA for Clinical Dosimetry with Emphasis on Clinical Trials QA for Clinical Dosimetry with Emphasis on Clinical Trials Geoffrey S. Ibbott, Ph.D. and RPC Staff G. Ibbott, AAPM Summer School, June 24, 2009 1 QA Infrastructure for Clinical Trials Participating Institutions

More information

IAEA experiences with QUATRO audits. J.Izewska, J. Zubizarreta Division of Human Health International Atomic Energy Agency

IAEA experiences with QUATRO audits. J.Izewska, J. Zubizarreta Division of Human Health International Atomic Energy Agency IAEA experiences with QUATRO audits J.Izewska, J. Zubizarreta Division of Human Health International Atomic Energy Agency Introduction of comprehensive audit The IAEA has recognized the need to audit medical

More information

Radiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions

Radiation Oncology. The conf ident path to treatment Philips Radiation Oncology Solutions Radiation Oncology The conf ident path to treatment Philips Radiation Oncology Solutions The confident path to treatment Philips Radiation Oncology Solutions Imaging Image registration Contouring Treatment

More information

Proton beam therapy: the hope and the hype

Proton beam therapy: the hope and the hype Proton beam therapy: the hope and the hype Professor Karol Sikora Chief Medical Officer Proton Partners International WelshConfed18 Protons The hope and the hype Professor Karol Sikora Chief Medical Officer

More information

A brief presentation of The TERA Foundation

A brief presentation of The TERA Foundation A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac

More information

Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon

Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Introduction Why Particle Therapy? PT Milestones What is meant by Industrialization Examples Protons-only:

More information

Intensity Modulated RadioTherapy

Intensity Modulated RadioTherapy Intensity Modulated RadioTherapy A clinical application of a small accelerator University Medical Center Groningen A.A. van t Veld PhD I. Hoveijn PhD part 1 part2 CERN/KVI accelerator school, Zeegse, June

More information

Hampton University Proton Therapy Institute

Hampton University Proton Therapy Institute Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI

More information

Small field diode dosimetry

Small field diode dosimetry Small field diode dosimetry Parham Alaei, Ph.D. Department of Radiation Oncology University of Minnesota NCCAAPM Symposium-October 10, 2013 1 Diodes as beam data collection detectors Diodes as in vivo

More information

Activities at the Heidelberg Ion Therapy Center (HIT)

Activities at the Heidelberg Ion Therapy Center (HIT) Activities at the Heidelberg Ion Therapy Center (HIT) The people A. Mairani (now INFN), F. Sommerer (Uniklinikum Heidelberg), I. Rinaldi (DKFZ Heidelberg), K. Parodi (HIT and University of Heidelberg)

More information

International Medical Physics Education and Training Needs Over the Next 20 Years

International Medical Physics Education and Training Needs Over the Next 20 Years Departments of Oncology and Medical Biophysics International Medical Physics Education and Training Needs Over the Next 20 Years Jacob (Jake) Van Dyk Professor Emeritus London, Ontario, Canada Objectives

More information

Treatment Planning (Protons vs. Photons)

Treatment Planning (Protons vs. Photons) Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield

More information

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT Received: 28 September 2017 Revised: 17 November 2017 Accepted: 28 December 2017 DOI: 10.1002/acm2.12276 RADIATION ONCOLOGY PHYSICS Normal tissue doses from MV image-guided radiation therapy (IGRT) using

More information

Neutron dose evaluation in radiotherapy

Neutron dose evaluation in radiotherapy Neutron dose evaluation in radiotherapy Francesco d Errico University of Pisa, Italy Yale University, USA Radiation therapy with a linear accelerator (LINAC) Photoneutron production in accelerator head

More information

PROTON THERAPY. MEDraysintell WORLD MARKET REPORT & DIRECTORY EDITION

PROTON THERAPY. MEDraysintell WORLD MARKET REPORT & DIRECTORY EDITION MEDraysintell PROTON THERAPY WORLD MARKET REPORT & DIRECTORY EDITION 2018 A report written by Paul-Emmanuel Goethals & Richard Zimmermann 2018 www.medraysintell.com Proton Therapy remains a niche market,

More information

Implementation of advanced RT Techniques

Implementation of advanced RT Techniques Implementation of advanced RT Techniques Tibor Major, PhD National Institute of Oncology Budapest, Hungary 2. Kongres radiološke tehnologije, Vukovar, 23-25. September 2016. Current RT equipments at NIO,

More information

7/10/2015. Acknowledgments. Institution-specific TG-142? AAPM:Task Group-142. Failure-Mode & Effects Analysis

7/10/2015. Acknowledgments. Institution-specific TG-142? AAPM:Task Group-142. Failure-Mode & Effects Analysis Acknowledgments Thanks to Saiful Huq for an illuminating conversation about the application of TG-100 Jennifer O Daniel, Ph.D. & Fang-Fang Yin, Ph.D. Duke University Medical Center Annual AAPM Meeting,

More information

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments

Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments Use of Bubble Detectors to Characterize Neutron Dose Distribution in a Radiotherapy Treatment Room used for IMRT treatments Alana Hudson *1 1 Tom Baker Cancer Centre, Department of Medical Physics, 1331

More information

Special Procedures Rotation I/II SBRT, SRS, TBI, and TSET

Special Procedures Rotation I/II SBRT, SRS, TBI, and TSET University of Michigan Department of Radiation Oncology Division of Radiation Physics Special Procedures Rotation I/II SBRT, SRS, TBI, and TSET Resident: Rotation staff mentor/ advisor: _Scott Hadley,

More information

An introduction to different types of radiotherapy

An introduction to different types of radiotherapy An introduction to different types of radiotherapy Radiotherapy can cure cancer. It is delivered to around half of cancer patients and is a vital part of curative treatment in around 40% of patients 1.

More information